Literature DB >> 16304569

Pediatric acute myeloid leukemia: international progress and future directions.

G J L Kaspers, U Creutzig.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16304569     DOI： 10.1038/sj.leu.2403958

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  42 in total

1.  The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study.

Authors:  Jan-Henning Klusmann; Dirk Reinhardt; Martin Zimmermann; Bernhard Kremens; Josef Vormoor; Michael Dworzak; Ursula Creutzig; Thomas Klingebiel
Journal:  Haematologica       Date:  2011-09-20       Impact factor: 9.941

2.  Predictive value of multidrug resistance proteins and cellular drug resistance in childhood relapsed acute lymphoblastic leukemia.

Authors:  Jan Styczynski; Mariusz Wysocki; Robert Debski; Krzysztof Czyzewski; Beata Kolodziej; Beata Rafinska; Malgorzata Kubicka; Sylwia Koltan; Andrzej Koltan; Monika Pogorzala; Andrzej Kurylak; Dorota Olszewska-Slonina; Walentyna Balwierz; Edyta Juraszewska; Maria Wieczorek; Igor Olejnik; Maryna Krawczuk-Rybak; Marta Kuzmicz; Jerzy Kowalczyk; Jolanta Stefaniak; Wanda Badowska; Danuta Sonta-Jakimczyk; Tomasz Szczepanski; Michal Matysiak; Iwona Malinowska; Elzbieta Stanczak; Jacek Wachowiak; Benigna Konatkowska; Lidia Gil; Anna Balcerska; Lucyna Maciejka-Kapuscinska
Journal:  J Cancer Res Clin Oncol       Date:  2007-08-02       Impact factor: 4.553

3.  Induction mortality and resource utilization in children treated for acute myeloid leukemia at free-standing pediatric hospitals in the United States.

Authors:  Marko Kavcic; Brian T Fisher; Yimei Li; Alix E Seif; Kari Torp; Dana M Walker; Yuan-Shung Huang; Grace E Lee; Sarah K Tasian; Marijana Vujkovic; Rochelle Bagatell; Richard Aplenc
Journal:  Cancer       Date:  2013-02-21       Impact factor: 6.860

4.  Combination of cladribine plus topotecan for recurrent or refractory pediatric acute myeloid leukemia.

Authors:  Hiroto Inaba; Clinton F Stewart; Kristine R Crews; Shengping Yang; Stanley Pounds; Ching-Hon Pui; Jeffrey E Rubnitz; Bassem I Razzouk; Raul C Ribeiro
Journal:  Cancer       Date:  2010-01-01       Impact factor: 6.860

5.  Inhibition of Rac GTPase signaling and downstream prosurvival Bcl-2 proteins as combination targeted therapy in MLL-AF9 leukemia.

Authors:  Benjamin Mizukawa; Junping Wei; Mahesh Shrestha; Mark Wunderlich; Fu-Sheng Chou; Andrea Griesinger; Chad E Harris; Ashish R Kumar; Yi Zheng; David A Williams; James C Mulloy
Journal:  Blood       Date:  2011-09-22       Impact factor: 22.113

6.  Comparison of administrative/billing data to expected protocol-mandated chemotherapy exposure in children with acute myeloid leukemia: A report from the Children's Oncology Group.

Authors:  Tamara P Miller; Andrea B Troxel; Yimei Li; Yuan-Shung Huang; Todd A Alonzo; Robert B Gerbing; Matt Hall; Kari Torp; Brian T Fisher; Rochelle Bagatell; Alix E Seif; Lillian Sung; Alan Gamis; David Rubin; Selina Luger; Richard Aplenc
Journal:  Pediatr Blood Cancer       Date:  2015-03-11       Impact factor: 3.167

7.  Use of clofarabine for acute childhood leukemia.

Authors:  A Pession; R Masetti; K Kleinschmidt; A Martoni
Journal:  Biologics       Date:  2010-06-24

Review 8.  Recent advances in management of acute myeloid leukemia (AML).

Authors:  Manasi Shah; Bharat Agarwal
Journal:  Indian J Pediatr       Date:  2008-09-04       Impact factor: 1.967

9.  Combination of cladribine and cytarabine is effective for childhood acute myeloid leukemia: results of the St Jude AML97 trial.

Authors:  J E Rubnitz; K R Crews; S Pounds; S Yang; D Campana; V V Gandhi; S C Raimondi; J R Downing; B I Razzouk; C-H Pui; R C Ribeiro
Journal:  Leukemia       Date:  2009-02-26       Impact factor: 11.528

10.  Idarubicin plus behenoyl cytarabine and 6-thioguanine compares favorably with idarubicin plus cytarabine-based regimen for children with previously untreated acute myeloid leukemia: 10-year retrospective, multicenter study in Korea.

Authors:  Dae Hyoung Lee; Nak Gyun Chung; Bin Cho; Hack Ki Kim; Hyoung Jin Kang; Hee Young Shin; Hyo Seop Ahn; Keon Hee Yoo; Ki Woong Sung; Hong Hoe Koo; Hoon Kook; Tai Ju Hwang; Ho Joon Im; Jong Jin Seo; Hyeon Jin Park
Journal:  J Korean Med Sci       Date:  2009-12-26       Impact factor: 2.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.